FRED STODDARD: Open Payments
NPI 1356397186 · VALLEJO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$370 in 7 payments from 5 companies in 2025. Trend: 2023 $1,059 · 2024 $761 · 2025 $370
Food & beverage: $370
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $130 |
| Neurocrine BioSciences, Inc. | 1 | $122 |
| ABBVIE INC. | 3 | $80 |
| Axsome Therapeutics, Inc. | 1 | $20 |
| Vanda Pharmaceuticals Inc. | 1 | $18 |
Products named: CAPLYTA, INGREZZA, VRAYLAR, Auvelity, FANAPT.
Industry payments across CA — which companies pay providers there.
